Biotech 2050 Podcast

Biotech 2050 Podcast

Biotech2050 Podcast is a think tank chronicling the disruptions changing the biotech industry over the next 50 years.

Tämä podcast on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi podcastin jaksot saattavat sisältää mainontaa.

Jaksot(265)

24. JoyL Silva, GM, and Nicole Strauss Pipeline Development and Innovation Lead, Pfizer CentreOne

24. JoyL Silva, GM, and Nicole Strauss Pipeline Development and Innovation Lead, Pfizer CentreOne

JoyL is the General Manager of Pfizer CentreOne, a global contract development and manufacturing organization (CDMO) and a leading supplier of specialty APIs embedded within Pfizer. In 2019, under her...

29 Heinä 202021min

23. Abbas Kazimi, VP of Business Development, Nimbus Therapeutics

23. Abbas Kazimi, VP of Business Development, Nimbus Therapeutics

Abbas Kazimi is the Vice President, Head of Business Development at Nimbus Therapeutics, a biotechnology company harnessing quantum mechanics and computational approaches to structural biology to desi...

22 Heinä 202031min

22. Randy Schatzman, Ph.D.,CEO and Board Member, Bolt Biotherapeutics

22. Randy Schatzman, Ph.D.,CEO and Board Member, Bolt Biotherapeutics

Dr. Randy Schatzman, Ph.D., is the chief executive officer and a board member of Bolt Biotherapeutics since 2019. He has over 30 years of biotechnology experience. Prior to Bolt, Dr. Schatzman was pre...

15 Heinä 202020min

21. Glenn Rosen, MD, Senior VP, Pre-Clinical Translational Sciences, Coherus BioSciences

21. Glenn Rosen, MD, Senior VP, Pre-Clinical Translational Sciences, Coherus BioSciences

Dr. Glenn Rosen has spent the bulk of his career engaged in basic and translational research in cancer and fibrosis. From 1993-2014, Dr. Rosen held a tenured faculty position in the Division of Pulmon...

9 Heinä 202033min

20. Diego Ardigò, MD, PhD, Head of Research and Development, Global Rare Diseases, Chiesi Group

20. Diego Ardigò, MD, PhD, Head of Research and Development, Global Rare Diseases, Chiesi Group

Diego is currently the Head of Research & Development of Global Rare Diseases at the Chiesi Group. Before this role, he was leading Chiesi’s development projects in rare diseases and advanced therapie...

1 Heinä 202022min

19. Mike Clayman, MD, CEO and Co-Founder, Flexion Therapeutics

19. Mike Clayman, MD, CEO and Co-Founder, Flexion Therapeutics

Dr. Clayman is a co-founder of Flexion Therapeutics and has served as our President, Chief Executive Officer and as one of our directors since our inception in 2007. Dr. Clayman also serves as the Cha...

24 Kesä 202025min

18. Grace Colón, PhD, President and CEO, InCarda Therapeutics

18. Grace Colón, PhD, President and CEO, InCarda Therapeutics

Dr. Colón brings over 25 years of experience in biopharma, genomics, healthcare and industrial biotechnology. In addition to her role at InCarda, she is Executive Chairman (formerly CEO) of ProterixBi...

17 Kesä 202022min

17. Sachin Chandran, PhD, Exec. Dir., Head of Pharmaceutical Sciences, Catabasis Pharmaceuticals

17. Sachin Chandran, PhD, Exec. Dir., Head of Pharmaceutical Sciences, Catabasis Pharmaceuticals

Recorded in January 2020, we spoke with Sachin Chandran, who is currently Executive Director and Head of Pharmaceutical Sciences at Catabasis Pharmaceuticals, Inc. in Boston. Sachin’s responsibilities...

10 Kesä 202023min

Suosittua kategoriassa Tiede

rss-mita-tulisi-tietaa
rss-poliisin-mieli
utelias-mieli
rss-hereilla
tiedekulma-podcast
rss-duodecim-lehti
rss-luontopodi-samuel-glassar-tutkii-luonnon-ihmeita
docemilia
rss-bios-podcast
hippokrateen-vastaanotolla
rss-ranskaa-raakana
rss-lihavuudesta-podcast
rss-radplus
rss-politiikasta-podcast
radio-antro
rss-tiedetta-vai-tarinaa